In an effort to promote a shared understanding of the range of issues, perspectives related to the use of asparaginase for adult Acute Lymphocytic Leukemia (ALL) patients in Canada, the CARE™ Hematology Faculty conducted a needs assessment. The shared insights help inform where treatment considerations lie and yields visibility on challenges/information needs to update practice and introduce new therapy.
Research led by:
Dr. Matthew Seftel (CancerCare Manitoba) &
Dr. James Whitlock (SickKids Hospital)